TESTICULAR INFARCTION

TESTICULAR INFARCTION was reported 60 times

TESTICULAR INFARCTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Lymphocyte Growth Factor [EPC] 1 0.0008
1 Tetracycline-class Drug [EPC] 15 0.0002
2 Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 2 0.0001
3 Interferon beta [EPC] 9 0.0000
4 Purine Antimetabolite [EPC] 4 0.0000
5 Dihydropyridine Calcium Channel Blocker [EPC] 10 0.0000
6 Aminosalicylate [EPC] 3 0.0000
7 Proton Pump Inhibitor [EPC] 14 0.0000
8 Platelet Aggregation Inhibitor [EPC] 13 0.0000
9 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
10 Ester Local Anesthetic [EPC] 1 0.0000
11 Complement Inhibitor [EPC] 1 0.0000
12 Nonsteroidal Anti-inflammatory Drug [EPC] 22 0.0000
13 Corticosteroid [EPC] 19 0.0000
14 Angiotensin Converting Enzyme Inhibitor [EPC] 2 0.0000
15 Non-Standardized Chemical Allergen [EPC] 1 0.0000
16 Arteriolar Vasodilator [EPC] 1 0.0000
17 Amide Local Anesthetic [EPC] 1 0.0000
18 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
19 Benzodiazepine [EPC] 7 0.0000
20 Antiarrhythmic [EPC] 1 0.0000
21 5-alpha Reductase Inhibitor [EPC] 1 0.0000
22 Interleukin-23 Antagonist [EPC] 1 0.0000
23 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
24 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
25 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
26 Prostacycline Vasodilator [EPC] 1 0.0000
27 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
28 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
29 Endothelin Receptor Antagonist [EPC] 1 0.0000
30 Thiazide Diuretic [EPC] 1 0.0000
31 Platinum-based Drug [EPC] 1 0.0000
32 Osmotic Laxative [EPC] 1 0.0000
33 Vitamin D [EPC] 1 0.0000
34 Vitamin B12 [EPC] 1 0.0000
35 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
36 Vitamin C [EPC] 1 0.0000
37 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
38 Insulin Analog [EPC] 1 0.0000
39 Tumor Necrosis Factor Blocker [EPC] 2 0.0000